Fulcrum Therapeutics, Inc. Collaboration Agreements
3 Contracts & Agreements
- First Amendment to Collaboration and License Agreement, effective as of April 20, 2023, by and between the Registrant and MyoKardia, Inc., a wholly-owned subsidiary of Bristol... (Filed With SEC on August 3, 2023)
- Collaboration and License Agreement, dated as of July 20, 2020, by and between the Registrant and MyoKardia, Inc (Filed With SEC on November 10, 2020)
- Collaboration and License Agreement, dated as of December 20, 2019, by and between the Registrant and Acceleron Pharma Inc (Filed With SEC on March 5, 2020)
